Ferumoxytol vs. Gadolinium Agents for Contrast-Enhanced MRI: Thoughts on Evolving Indications, Risks, and Benefits

Journal of Magnetic Resonance Imaging - United States
doi 10.1002/jmri.25827
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Gadolinium-Based Contrast Agents for Magnetic Resonance Cancerimaging

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
MedicineBioengineeringNanotechnologyBiomedical EngineeringNanoscience
2012English

Brain Gadolinium Deposition After Administration of Gadolinium-Based Contrast Agents

Japanese Journal of Radiology
Nuclear MedicineRadiologyImaging
2015English

Contrast Enhanced Spectral Mammography (CESM) Indications

The Bangkok Medical Journal
2014English

Supramolecular Aggregates of Amphiphilic Gadolinium Complexes as Blood Pool MRI/MRA Contrast Agents: Physicochemical Characterization

English

Polycatechol Nanoparticle MRI Contrast Agents

Small
Materials ScienceNanoscienceEngineeringBiomaterialsMedicineBiotechnologyNanotechnologyChemistry
2015English

Whole Body MRI for Breast Cancer Staging: The Roles of the Field Strength and Gadolinium Contrast Agents in Focus

Madridge Journal of Oncogenesis
2018English

The Benefits and Risks of Vasoactive Agents

Southern African Journal of Anaesthesia and Analgesia
AnesthesiologyPain Medicine
2014English

Synergistic Enhancement of Iron Oxide Nanoparticle and Gadolinium for Dual-Contrast MRI

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2012English

Dynamic Contrast-Enhanced Area-Detector CT vs Dynamic Contrast-Enhanced Perfusion MRI vs FDG-PET/CT: Comparison of Utility for Quantitative Therapeutic Outcome Prediction for NSCLC Patients Undergoing Chemoradiotherapy

Magnetic Resonance in Medical Sciences
Nuclear MedicineRadiologyImaging
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy